The physicist's role in total body irradiation treatments

Total body irradiation (TBI) remains one of the more demanding regimens in radiation oncology, used most often as part of conditioning before bone marrow transplantation for leukaemia and selected solid tumours. The medical physicist sits at the centre of every step, from commissioning the treatment unit through to checking the dose a patient actually receives each morning. Because TBI targets large, irregular fields at extended source-to-skin distance, the tolerances that govern conventional radiotherapy are tightened, and the margin for geometric or dosimetric error shrinks accordingly.

At the 2014 Annual Scientific Meeting of the Canadian Organization of Medical Physicists in Banff, delegates shared protocols, audit results, and translational work that resonated well beyond Canada. Australian centres sent sizeable contingents to the meeting, reflecting how deeply the country has invested in advanced radiotherapy physics. Sessions on dosimetry, motion management, and quality assurance mapped closely onto challenges faced at home, from the bunkers of Sydney's Liverpool Hospital to the photon fluence monitors at Melbourne's Peter MacCallum Cancer Centre.

Treatment planning foundations for TBI

A TBI plan begins long before the first fraction. The physicist is responsible for commissioning the linear accelerator in the TBI configuration, validating the output at the extended treatment distance, and characterising the beam across the full clinical field. PDD, profile, and output factor measurements must be cross-checked against the treatment planning system, and any couch, spoiler, or compensator geometry has to be modelled carefully. At Peter MacCallum, physicists worked alongside radiation oncologists to define a reference mid-plane dose and a consistent prescription point, which became the foundation for every subsequent patient calculation.

Once a patient is referred, the physicist contributes to immobilisation decisions, CT simulation protocols, and the choice of beam arrangement. Whether the centre uses bilateral fields, AP/PA, or rotational techniques, the physicist verifies that the dose distribution matches the prescription across the lungs, kidneys, and head. Heterogeneity corrections, lung shielding design, and compensator fabrication all sit within the physicist's portfolio, and they require continuous dialogue with the treating oncologist. Australian centres have increasingly adopted 3D-printed compensators, with several metropolitan departments reporting early experience that aligns with international practice.

In-vivo dosimetry and patient-specific verification

Even with careful planning, the daily reality of TBI introduces variability that only direct measurement can capture. In-vivo dosimetry, whether using diodes, thermoluminescent dosimeters, or MOSFETs, allows the physicist to confirm that the prescribed dose reaches the patient as intended. Entrance and exit dose measurements on the first fraction typically establish the baseline, and subsequent checks catch shifts in patient position, couch height, or beam output. At Liverpool Hospital, physicists built a workflow that flags any deviation greater than three per cent for immediate review, a threshold that has become a useful benchmark in the Australian setting.

The Australian Clinical Dosimetry Service has encouraged hospitals to participate in independent credentialing, and several TBI programmes have now submitted their in-vivo workflows for external audit. Discussions at the Banff meeting covered how such audits can be structured for low-dose-rate and high-dose-rate regimens alike. Readers interested in the broader findings can review the Canadian dosimetry audit outcomes presented at the same conference.

Quality assurance programme structure

A mature TBI service runs on a quality assurance programme that is documented, version-controlled, and reviewed at least annually. The physicist typically authors the programme and owns its execution, including machine QA, patient-specific QA, and end-to-end testing of any new technique. Linear accelerator constancy checks must cover the TBI mode separately, because output at extended distance behaves differently from conventional reference conditions. Monthly output checks, weekly phantom measurements, and daily morning warm-up tests form the backbone of most institutional schedules.

Routine dosimetry verification tasks that many Australian programmes treat as non-negotiable include:

• Output constancy at the TBI treatment distance, measured with a calibrated ion chamber in a water phantom
• Timer linearity and end-effect corrections for extended irradiation times
• Profile symmetry and flatness across the maximum clinical field
• Spoiler-to-skin distance verification and PDD re-measurement after any couch change
• Couch speed accuracy for translating-beam techniques, cross-checked with a stopwatch and fiducial markers

Clinical technique selection and translational research

Choosing between AP/PA, lateral bilateral, sweeping beam, or arc techniques depends on bunker geometry, patient cohort, and institutional experience. Physicists play a central role in evaluating trade-offs between homogeneity, integral dose, and delivery time. Translational work at the Peter MacCallum Cancer Centre explored the use of volumetric modulated arc therapy for partial bone marrow sparing in paediatric recipients, a project that required extensive physicist-led modelling before any patient was treated. Such initiatives highlight how the physicist's role extends from routine clinical support into research and development, with mentorship of junior staff woven throughout.

Conference sessions in Banff also featured updates on tomotherapy-based TBI and on dedicated TBI suites with translating couches. The economics and logistics of these installations matter to Australian hospitals, where capital expenditure decisions often flow through state health departments rather than individual institutions. Sharing data on commissioning timelines, staffing, and maintenance costs helps smaller Australian centres benchmark whether an upgrade is feasible within their funding cycle.

Safety culture, incident learning, and governance

Safety in TBI is shaped by both technical controls and institutional culture. The physicist usually leads the failure modes and effects analysis for the TBI pathway, identifying where errors are most likely and where defences are thinnest. Lung shielding errors, incorrect SSD readings, and transcription mistakes in the prescription are recurring themes in incident reports worldwide. ARPANSA guidance provides an Australian regulatory backdrop, and the agency encourages transparent reporting through local incident learning systems so that lessons propagate across jurisdictions.

For departments building or refreshing their TBI governance framework, the following elements are worth considering:

• A written risk register specific to TBI, reviewed at each multidisciplinary meeting
• Independent calculation of mid-plane dose by a second physicist before the first fraction
• Standardised prescription templates that prevent handwritten dose ambiguities
• Documented competency requirements for physics, radiation therapy, and nursing staff
• Post-treatment chart rounds within 48 hours of the final fraction to confirm delivered dose

Professional engagement and conference value

Continuing professional development underpins safe TBI practice, and conferences remain a key venue for sharing protocols and absorbing new evidence. The CCPM examinations, business meetings, and scientific sessions at Banff attracted physicists at every career stage, from first-year residents to senior department heads. Many Australian attendees used the meeting to reconnect with colleagues from New Zealand, Singapore, and the broader Asia-Pacific region, exchanging notes on technique and training while also sampling the mountain scenery that draws delegates to the Canadian Rockies each year.

The gathering also had tangible economic and scientific effects on its host community, a topic explored in the article on the-economic-impact-of-medical-physics-conferences-on-banff. Delegates left Banff with new calibration data, refreshed QA templates, and a clearer sense of where the physics community is heading next.

The abstracts, posters, and presentation slides from the 2014 meeting remain available through the conference archive, and physicists planning a new TBI programme or refreshing an existing one are encouraged to explore those resources. Sharing protocols, audit results, and incident learnings strengthens the entire community, and continued collaboration between Canadian, Australian, and international centres will shape the next generation of TBI practice.